Imaging Biomarkers Driving Clinical Innovations Interview

February 16, 2021 | Coverage

In the drive to advance personalized medicine, researchers are increasingly turning to radiomics to assist in the discovery of new types of biomarkers.

Biomarkers offer clinical researchers and drug developers ways to elevate patient care, work toward more preventive measures, identify appropriate study candidates, and more. Now, researchers are turning to advanced imaging analytical technology, or radiomics, to discover new kinds of biomarkers and take their work to the next level.

Rose Higgins (RH), CEO of HealthMyne, discussed with Outsourcing-Pharma (OSP) how radiomics works, recent developments in biomarker technology, and what might lie ahead.